1. Home
  2. WS vs BCRX Comparison

WS vs BCRX Comparison

Compare WS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$32.28

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.21

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
BCRX
Founded
1955
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
WS
BCRX
Price
$32.28
$8.21
Analyst Decision
Buy
Strong Buy
Analyst Count
1
11
Target Price
$47.00
$20.82
AVG Volume (30 Days)
210.1K
4.1M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
1.96%
N/A
EPS Growth
N/A
381.40
EPS
1.10
1.21
Revenue
$3,093,300,000.00
$25,186,000.00
Revenue This Year
$21.33
N/A
Revenue Next Year
$3.41
$12.55
P/E Ratio
$29.67
$6.93
Revenue Growth
N/A
N/A
52 Week Low
$21.30
$6.00
52 Week High
$49.17
$11.31

Technical Indicators

Market Signals
Indicator
WS
BCRX
Relative Strength Index (RSI) 21.32 57.26
Support Level $29.63 $7.95
Resistance Level $33.09 $8.68
Average True Range (ATR) 1.51 0.33
MACD -1.20 -0.01
Stochastic Oscillator 6.37 51.57

Price Performance

Historical Comparison
WS
BCRX

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: